Pages that link to "Q54541989"
Jump to navigation
Jump to search
The following pages link to Infections in cancer patients.Results with gentamicin sulfate therapy (Q54541989):
Displaying 50 items.
- Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia (Q24201767) (← links)
- Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia (Q24248048) (← links)
- A novel use of gentamicin in the ROS-mediated sensitization of NCI-H460 lung cancer cells to various anticancer agents (Q28393238) (← links)
- Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials (Q30756968) (← links)
- Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis (Q31143077) (← links)
- Mezlocillin for treatment of infections in cancer patients (Q33730391) (← links)
- Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients (Q33731809) (← links)
- Infections in cancer patients (Q34054315) (← links)
- Effects of cytotoxic and immunosuppressive agents on the immune system (Q34072063) (← links)
- Human pharmacology of 6-[D-alpha-(3-guanylureido)-phenylacetamido]-penicillanic acid (BL-P1654). (Q34904238) (← links)
- Empiric Therapy for Cancer Patients: Comparative Study of Ticarcillin-Tobramycin, Ticarcillin-Cephalothin, and Cephalothin-Tobramycin (Q34928940) (← links)
- Synergistic activity of carbenicillin and gentamicin in experimental Pseudomonas bacteremia in neutropenic rats (Q34981359) (← links)
- Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy (Q35540674) (← links)
- Infections caused by gram-negative pathogens: new clinical considerations (Q35541847) (← links)
- Ticarcillin Therapy of Infections (Q35653667) (← links)
- Leukocyte transfusions for the prophylaxis and treatment of infections associated with granulocytopenia (Q35816439) (← links)
- Newer Antibacterial and Antimycotic Drugs: Critical Appraisal (Q35877334) (← links)
- Combination therapy for treatment of infections with gram-negative bacteria (Q36156077) (← links)
- Mezlocillin: in vitro studies of a new broad-spectrum penicillin (Q36458437) (← links)
- Azlocillin: In Vitro Studies of a New Semisynthetic Penicillin (Q36462997) (← links)
- Pharmacology and efficacy of netilmicin (Q36469912) (← links)
- Piperacillin: In Vitro Evaluation (Q36472026) (← links)
- Pseudomonas aeruginosa Infection in Cancer Patients (Q36756527) (← links)
- Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? (Q37884104) (← links)
- The Norwegian experience with penicillin G plus an aminoglycoside as initial empiric therapy in febrile neutropenia; a review (Q37969132) (← links)
- Pulmonary infections in immunocompromised children (Q38785599) (← links)
- Neutrophils collection and transfusion for the treatment of infection in neutropenic patients (Q39082633) (← links)
- Imipenem-antibiotic monotherapy in juvenile cancer patients with neutropenia (Q39261281) (← links)
- Controversies in the management of febrile neutropenic cancer patients (Q39603225) (← links)
- Why Monitor Serum Levels of Gentamicin? (Q39725314) (← links)
- Antibacterial therapy in patients with malignancies (Q39760912) (← links)
- Antibacterial and immunostimulatory properties of chemotactic N-formyl peptide conjugates of ampicillin and amoxicillin (Q39819887) (← links)
- Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro model (Q39833928) (← links)
- Infectious complications in the cancer patient (Q39863147) (← links)
- Combination Antimicrobial Therapy (Q40145535) (← links)
- Infections in children with acute leukemia (Q40305640) (← links)
- In Vitro Model Simulating the Form of Exposure of Bacteria to Antimicrobial Drugs Encountered in Infection (Q40620708) (← links)
- Empiric treatment of fever in acute leukaemia with tobramycin-cephalothin, and the escape clause provision of corticosteroids (Q40864054) (← links)
- A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients (Q40866399) (← links)
- Granulocyte Transfusion: A Controlled Study in Patients with Acute Nonlymphocytic Leukemia (Q40894062) (← links)
- Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study. (Q41091116) (← links)
- Infections in neutropenic patients. II: Management (Q41164565) (← links)
- Controversies in the antibacterial treatment of patients with neutropenia: a matter of comprehension or apprehension? (Q41348034) (← links)
- Comparative study of three routes of administration of sisomicin (Q43638326) (← links)
- The role of schedule of antibiotic therapy on the neutropenic patient (Q43704782) (← links)
- Host defence mechanisms, antibiotics and immunosuppressive agents--a complex relationship (Q44473982) (← links)
- Synthesis and biological activity of N-Acylated ornithine analogues of daptomycin (Q44658886) (← links)
- Supportive care in bone marrow failure. Technical, immunological and clinical advances (Q45224578) (← links)
- Successful control of systemic Aspergillus niger infections in two patients with acute leukemia (Q66848601) (← links)
- Use of antibiotics. Infection in the compromised host (Q66877596) (← links)